ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 30.77

Change

-0.15 (-0.49)%

Market Cap

N/A

Volume

300.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.02 (+0.03%)

CAD 5.29B
PHYS-U:CA Sprott Physical Gold Trust

+0.17 (+0.87%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.35 (+1.00%)

CAD 4.54B
XEQT:CA iShares Core Equity Portfolio

+0.31 (+0.99%)

CAD 4.46B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.38 (+1.65%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.29 (+3.00%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.03 (+0.14%)

CAD 2.52B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.45% 58% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.45% 57% F 48% F
Trailing 12 Months  
Capital Gain 5.96% 30% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.96% 28% F 30% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.62% 43% F 41% F
Dividend Return 0.62% 41% F 32% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2.03% 92% A 97% N/A
Risk Adjusted Return 30.37% 55% F 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.